Role of FDG-PET/CT for monitoring soft tissue tumors

Oncol Lett. 2014 Apr;7(4):1243-1248. doi: 10.3892/ol.2014.1876. Epub 2014 Feb 12.

Abstract

The aim of the current study was to evaluate the limitations of 2-deoxy-2-F18-fluoro-D-glucose positron emission tomography combined with computed tomography (FDG-PET/CT) when monitoring soft tissue tumors. The diagnostic criteria of malignancy was defined as the tumor having a maximum standardized uptake value (SUVmax) ≥2.0 and a maximum diameter ≥5 cm as measured using FDG-PET/CT. One-hundred-and-thirteen patients, that were either included in the criteria or not, were compared. In addition, the values of SUVmax of the primary tumor and relapse in 12 patients were evaluated. The Kaplan-Meier analysis demonstrated that patients with tumors measuring ≥5 cm size and ≥2.0 SUVmax were associated with a worse survival rate. Among the 12 patients with relapse, statistical significances were detected in the tumor diameters, however, not in the SUVmax values. Thus, the criteria identified patients that were associated with a poor prognosis, and the SUVmax of distant metastases and local recurrences were identified to be significantly affected by tumor size.

Keywords: 2-deoxy-2-F18-fluoro-D-glucose positron emission tomography; computed tomography; maximum standardized uptake value; metastasis; prognosis; recurrence; soft tissue tumor.